Johnson & Johnson operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Johnson & Johnson with three other
major healthcare and pharmaceutical companies:
Bristol-Myers Squibb Company
sales of $16.56 billion
of which 100%
Baxter International Inc.
of which 62%
was Hospital Products), and
based in Switzerland
(48.55 billion Swiss Francs [US$50.06 billion]
of which 60%
During the year ended December of 2015, sales at
Johnson & Johnson were $70.07 billion.
decrease of 5.7%
versus 2014, when the company's sales were $74.33 billion.
Contributing to the drop in overall sales was the 8.7% decline
in Medical Devices and Diagnostics, from $27.52 billion to $25.14 billion.
There were also decreases in sales in
Pharmaceutical (down 2.7% to $31.43 billion)
Consumer (down 6.8% to $13.51 billion)